Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer

Jean‐Philippe Theurillat(Broad Institute), Namrata D. Udeshi(Broad Institute), Wesley J. Errington(University Health Network), Tanya Svinkina(Broad Institute), Sylvan C. Baca(Harvard University), Marius Pop(Broad Institute), Peter J. Wild(University Hospital of Zurich), Mirjam Blattner(Cornell University), Anna C. Groner(Dana-Farber Cancer Institute), Mark A. Rubin(Cornell University), Holger Moch(University Hospital of Zurich), Gilbert G. Privé(University Health Network), Steven A. Carr(Broad Institute), Levi A. Garraway(Broad Institute)
Science
October 2, 2014
Cited by 256Open Access
Full Text

Abstract

Cancer genome characterization has revealed driver mutations in genes that govern ubiquitylation; however, the mechanisms by which these alterations promote tumorigenesis remain incompletely characterized. Here, we analyzed changes in the ubiquitin landscape induced by prostate cancer-associated mutations of SPOP, an E3 ubiquitin ligase substrate-binding protein. SPOP mutants impaired ubiquitylation of a subset of proteins in a dominant-negative fashion. Of these, DEK and TRIM24 emerged as effector substrates consistently up-regulated by SPOP mutants. We highlight DEK as a SPOP substrate that exhibited decreases in ubiquitylation and proteasomal degradation resulting from heteromeric complexes of wild-type and mutant SPOP protein. DEK stabilization promoted prostate epithelial cell invasion, which implicated DEK as an oncogenic effector. More generally, these results provide a framework to decipher tumorigenic mechanisms linked to dysregulated ubiquitylation.


Related Papers